BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15298533)

  • 21. Impact of 'Chief-Pharmacist System' on drug expenditures and rational drug use.
    Ma Z; Zhao Z; Sun S; Li Y; An Z; Yan Y; Liu L
    Int J Clin Pharm; 2020 Feb; 42(1):167-173. PubMed ID: 31919733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Have consultant pharmacists provided value to long-term care payers?
    Vogenberg FR; Dhir S
    Consult Pharm; 2006 Jan; 21(1):72-5. PubMed ID: 16524354
    [No Abstract]   [Full Text] [Related]  

  • 23. Econometric studies on pharmacist care services are lacking--a call for papers.
    Soller RW
    Int J Pharm Pract; 2012 Apr; 20(2):69-70. PubMed ID: 22416930
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
    Till LT; Voris JC; Horst JB
    J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceived successes and challenges of clinical pharmacist practitioners in North Carolina.
    Hale JC; Murawski MM; Ives TJ
    J Am Pharm Assoc (2003); 2013; 53(6):640-3. PubMed ID: 24185431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing pharmacy services in a primary care setting to help providers improve quality performance measures.
    Moore R; Nickerson-Troy J; Morse K; Finley K
    Am J Health Syst Pharm; 2019 Sep; 76(19):1460-1461. PubMed ID: 31504111
    [No Abstract]   [Full Text] [Related]  

  • 27. Spirometry: tool for pharmacy practitioners to expand direct patient care services.
    Cawley MJ; Moon J; Reinhold J; Willey VJ; Warning Ii WJ
    J Am Pharm Assoc (2003); 2013; 53(3):307-15. PubMed ID: 23699680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
    Desborough JA; Sach T; Bhattacharya D; Holland RC; Wright DJ
    Int J Pharm Pract; 2012 Feb; 20(1):41-9. PubMed ID: 22236179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the revenue cycle to promote growth of the pharmacy enterprise.
    O'Neal BC; Friemel AM; Glowczewski JE; Coggins JM; Macchia M; Forrey RA; Patel KR; Granko RP
    Am J Health Syst Pharm; 2018 Jun; 75(12):853-855. PubMed ID: 29880521
    [No Abstract]   [Full Text] [Related]  

  • 30. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist-managed headache clinic.
    Weitzel KW; Presley DN; Showalter ML; Seymour S; Waddell RF
    Am J Health Syst Pharm; 2004 Dec; 61(23):2548-50. PubMed ID: 15595231
    [No Abstract]   [Full Text] [Related]  

  • 32. Remunerated patient care services and injections by pharmacists: An international update.
    Houle SKD; Carter CA; Tsuyuki RT; Grindrod KA
    J Am Pharm Assoc (2003); 2019; 59(1):89-107. PubMed ID: 30195440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacists need recognition as providers to enhance patient care.
    White CM
    Ann Pharmacother; 2014 Feb; 48(2):268-73. PubMed ID: 24259647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How did we get here from there?
    Schuh MJ
    J Am Pharm Assoc (2003); 2008; 48(4):442-4. PubMed ID: 18653413
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations.
    Perraudin C; Bugnon O; Pelletier-Fleury N
    Health Policy; 2016 Dec; 120(12):1350-1362. PubMed ID: 28228230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandora's Prescription: The Pharmaceutical Pricing
    Pederson T
    FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
    [No Abstract]   [Full Text] [Related]  

  • 37. Better Care, Smarter Spending, Healthier Outcomes.
    McGann P
    Consult Pharm; 2016; 31(8):410-1. PubMed ID: 27535075
    [No Abstract]   [Full Text] [Related]  

  • 38. Going out on your own: how to determine the value of your clinical services.
    Martin CM
    Consult Pharm; 2009 Nov; 24(11):817-22. PubMed ID: 20092219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promising results revealed in Mississippi disease management program. But program has low pharmacist participation.
    Young D
    Am J Health Syst Pharm; 2003 Sep; 60(17):1720, 1722, 1724. PubMed ID: 14503106
    [No Abstract]   [Full Text] [Related]  

  • 40. Emerging roles for pharmacists in performance-based risk-sharing arrangements.
    Calabrese MJ; Cooke CE; Watson K; de Bittner MR
    Am J Health Syst Pharm; 2017 Jul; 74(13):1007-1012. PubMed ID: 28522641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.